Chris Nolet

Insider Reports History

Location
Newark, CA
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Nolet:

Company Role Class Num Shares Value Price $ Report Date Ownership
POLARITYTE, INC. Director Common Stock 14,403 $11,383 $0.7903 12 Jan 2023 Direct
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23,458 01 May 2024 Direct
ArriVent BioPharma, Inc. Director Non-Qualified Stock Option (right to buy) 15,502 18 Jun 2025 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7,500 03 Jul 2025 Direct
POLARITYTE, INC. Director Stock option (right to buy) 6,157 12 Jan 2023 Direct

Insider Reports Filed by Chris Nolet

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JSPR Jasper Therapeutics, Inc. 03 Jul 2025 1 $0 4 Director 03 Jul 2025, 16:23
AVBP ArriVent BioPharma, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 19:29
/report/000095017025015339-nolet-chris-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 2 -$104,412 4 Director 06 Feb 2025, 15:48
JSPR Jasper Therapeutics, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 18:28
/report/000147929024000088-nolet-chris-2024-05-01 Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:46
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 1 $0 4 Director 29 Jan 2024, 16:16
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 Director 25 Jan 2024, 20:39
JSPR Jasper Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:42
/report/000147929023000062-nolet-chris-2023-05-03 Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:14
/report/000149315223001628-nolet-chris-2023-01-12 POLARITYTE, INC. 12 Jan 2023 2 $0 4 Director 17 Jan 2023, 15:30
JSPR Jasper Therapeutics, Inc. 12 Oct 2022 1 $0 4 Director 13 Oct 2022, 20:00
/report/000149315222027578-nolet-chris-2022-10-01 POLARITYTE, INC. 01 Oct 2022 1 $0 4 Director 04 Oct 2022, 17:00
/report/000147929022000067-nolet-chris-2022-05-04-restatement Revance Therapeutics, Inc. 04 May 2022 1 $0 4/A Director 13 May 2022, 18:11
JSPR Jasper Therapeutics, Inc. 21 Mar 2022 1 $0 4 Director 23 Mar 2022, 18:01
JSPR Jasper Therapeutics, Inc. 24 Sep 2021 0 $0 3 Director 01 Oct 2021, 16:09
/report/000147929021000112-nolet-chris-2021-05-05 Revance Therapeutics, Inc. 05 May 2021 2 $0 4 Director 07 May 2021, 19:10